Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements in the latest release.
    Difference
    0.0%
    Check dated 2024-10-03T05:34:42.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    New interventions and treatments have been added to the study, including Fulvestrant, Letrozole, and Palbociclib, with detailed information on study locations and participant groups, while previous notices about delays in displaying study record information have been removed.
    Difference
    14%
    Check dated 2024-09-25T23:14:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    0.6%
    Check dated 2024-09-18T17:18:29.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The website has posted a new last update on September 3, 2024, replacing the estimated last update from September 2, 2024.
    Difference
    0.1%
    Check dated 2024-09-11T09:10:49.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A new Phase II study has been added focusing on the combination of Pembrolizumab, Letrozole, and Palbociclib for treating postmenopausal patients with newly diagnosed metastatic Stage IV estrogen receptor-positive breast cancer, while a previous study with similar focus has been removed.
    Difference
    14%
    Check dated 2024-09-04T06:21:44.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.0%
    Check dated 2024-08-14T00:49:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.